SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India - Quaterly Results

14 May 2025 Evaluate
The total revenue for the quarter ended March 2025 remained nearly unchanged at Rs. 5359.00 millions.Profit after tax for the quarter ended March 2025 reported a huge growth of 65.97% to Rs. 1195.00  millions from Rs. 720.00 millions.Operating profit surged to 1752.00 millions from the corresponding previous quarter of 1406.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202412 202312 % Var
Sales 5359.00 5108.00 4.91 5359.00 5108.00 4.91 20132.00 19961.00 0.86
Other Income 33.00 35.00 -5.71 33.00 35.00 -5.71 165.00 612.00 -73.04
PBIDT 1752.00 1406.00 24.61 1752.00 1406.00 24.61 5073.00 5489.00 -7.58
Interest 3.00 3.00 0.00 3.00 3.00 0.00 15.00 17.00 -11.76
PBDT 1749.00 1136.00 53.96 1749.00 1136.00 53.96 4681.00 5650.00 -17.15
Depreciation 96.00 91.00 5.49 96.00 91.00 5.49 367.00 365.00 0.55
PBT 1653.00 1045.00 58.18 1653.00 1045.00 58.18 4314.00 5285.00 -18.37
TAX 458.00 325.00 40.92 458.00 325.00 40.92 1177.00 1639.00 -28.19
Deferred Tax 1.00 -72.00 -101.39 1.00 -72.00 -101.39 -81.00 5.00 -1720.00
PAT 1195.00 720.00 65.97 1195.00 720.00 65.97 3137.00 3646.00 -13.96
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 32.69 27.53 18.77 32.69 27.53 18.77 25.20 27.50 -8.36

Sanofi India Share Price

3493.20 23.65 (0.68%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×